Literature DB >> 4263745

The effects of steroids on glucose-6-phosphate dehydrogenase.

G W Oertel, P Benes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4263745     DOI： 10.1016/0022-4731(72)90095-7

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN： 0022-4731            Impact factor:   4.292


× No keyword cloud information.
  7 in total

1.  Interaction between dehydroepiandrosterone, cyclic adenosine-3',5'-monophosphate and glucose-6-phosphate-dehydrogenase in normal and diseased subjects.

Authors:  G W Oertel; P Benes; M Schirazi; H Holzmann; G Hoffmann
Journal:  Experientia       Date:  1974-08-15

2.  Free and sulfoconjugated dehydroepiandrosterone, cyclic adenosime-3',5'-monophosphate, and free estriol in maternal and cord blood.

Authors:  G Guez; R Gandar; E Schuy; P Knapstein; G Oertel
Journal:  Experientia       Date:  1976-01-15

3.  Interaction between dehydroepiandrosterone, glucose-6-phosphate dehydrogenase, and cyclic adenosine-3',5'-monophosphate in neoplastic and normal human mammary tissue.

Authors:  G W Oertel; P Benes; G Hoffmann; E Schuy
Journal:  Experientia       Date:  1975-10-15

Review 4.  The effects of dehydroepiandrosterone on carcinogenesis, obesity, the immune system, and aging.

Authors:  J R Williams
Journal:  Lipids       Date:  2000-03       Impact factor: 1.880

5.  Prevention of obesity in Avy/a mice by dehydroepiandrosterone.

Authors:  T T Yen; J A Allan; D V Pearson; J M Acton; M M Greenberg
Journal:  Lipids       Date:  1977-05       Impact factor: 1.880

6.  Prevention by dehydroepiandrosterone of the development of mammary carcinoma induced by 7,12-dimethylbenz(a)anthracene (DMBA) in the rat.

Authors:  S Li; X Yan; A Bélanger; F Labrie
Journal:  Breast Cancer Res Treat       Date:  1994-02       Impact factor: 4.872

7.  Simultaneous dual targeting of Par-4 and G6PD: a promising new approach in cancer therapy? Quintessence of a literature review on survival requirements of tumor cells.

Authors:  Ingeborg Elisabeth Cernaj
Journal:  Cancer Cell Int       Date:  2016-11-15       Impact factor: 5.722
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.